Board of Advisors
Our Board of Advisors, all industry leaders, have made a powerful statement by supporting Life Science Cares and our goal to end poverty in our community. Our Advisors make a personal financial contribution annually to make our mission and model possible.
Our Board of Advisor members also choose to volunteer with their companies and recruit their colleagues to join in this collective effort.
NEW YORK BOARD OF ADVISORS
ABCDEFGHIJKLMNOPQRSTUVWXYZ
Michael Aberman
General Partner – Regeneron Ventures
Robin Abrams
Chief Legal Officer and Corporate Secretary – Altimmune, Inc.
Vineet Agarwal
Chief Financial Officer – Korro Bio
Sandip Agarwala
Managing Director – Blue Owl Capital
Samuel Bakhoum
Chief Scientific Officer and Co-founder – Volastra Therapeutics
Christophe Beauduin
Special Counsel – Cooley
Dan Becker
Managing Director – Access Biotechnology
Nikhil Bhide
VP, Head of U.S. Business Development & Strategy – Ferring Pharmaceuticals
Valerie Bowling
Executive Director – The Conference Forum
Geoff Brzuchalski
Partner – PwC
Alexandra Cantley
Partner – Polaris Partners
Kyle Carver
Chief Financial Officer – Evommune
Cara Cassino
President – Stony Point Life Sciences Consulting LLC
Kerry Clem
CCO – Solaxa
Ashish Contractor
Managing Director – Moelis & Company
Sue Crinnion
Managing Director, Life Sciences Venture Banking – Banc of California
Bryan Czyzewski
Managing Director – Jefferies
Guilerme (Will) Debarros
Northeast Life Sciences & Technology Practice Leader – Marsh McLennan Agency
Mark Dempster
IB Managing Director – Stifel Financial Corp.
Raymond Facinelli
Executive Vice President – Capital Advisors Group
Anthony Fiorino
SVP and Head of Clinical Development – EvolveImmune Therapeutics
Zandy Forbes
CEO – MeiraGTx
Martin Friedman
Managing Member – Pharmakon Advisors
Anjali Ganguli
Chief Business Officer – Syndax Pharmaceuticals
Matthew Gline
CEO – Roivant Sciences
Dan Gold
President – Fairway Consulting Group
Adam Golden
Partner, Global Head of Life Sciences – Freshfields
Lee Golodny
Managing Director – ZRG
Carl Gordon
Managing Partner – OrbiMed
Ruby Grewal
Executive in Residence – Roivant
Johanna Grossman
Head of Healthcare & Life Sciences, Capital Markets – New York Stock Exchange
Div Gupta
Partner – Cooley LLP
Bill Hartman
Vice Chairman – CBRE, Inc
Bill Harvey
Executive Vice President – JLL
Jennifer Hawks Bland
CEO – NewYorkBIO
Amir Hefni
CEO – Resolution Therapeutics
Jane Henderson
Chief Financial Officer – Apogee Therapeutics
Laurent Hermouet
Partner – Athyrium
William Holodnak
Chief Executive Officer & Founder – Occam Global
Christopher Holterhoff
Biotech Business & Corporate Development/Finance – Consultant
Colleen Tracy James
Partner – Cahill Gordon & Reindel LLP
Michael Jiang
Senior Managing Director – Guggenheim Securities
Ginger Johnson
President – Lumanity
Darren Jones
Partner – Baker Tilly
Bj Jones
Chief Commercial Officer – NewAmsterdam Pharma
Sophie Jones
Chief Financial Officer – Seismic Therapeutic
Ted Kalem
President – HRA Capital
Daphne Karydas
President and CFO – Flare Therapeutics
Anna Kazanchyan
Founder and CEO – Saghmos Therapeutics
Dr. Grace Kim
Chief Strategy Officer – Multiple Biopharma Companies
Andrew Lam
Managing Director, Head of Biotech Private Equity – Ally Bridge Group
Cristina Larkin
CEO – CLC Insights LLC
Rob Lauzen
Chief Financial Officer – Circle Pharma, Inc.
Matthew Leskowitz
Managing Director – Goldman Sachs
Susanna Ling
Senior Vice President – Cure
Scott Lunin
Partner – WilmerHale
Michael Margolis
Senior Managing Director – Oppenheimer & Co. Inc.
Nicole McKnight
President and COO – Buckle Therapeutics
Rachel Mears
Managing Partner – Kenai Strategic Advisors
Scott Metzner
Founder & Principal – Janus Property
Rose Mistri Somers
Managing Director – Russell Reynolds Associates
Alison Morrissey
Partner – McCarter & English, LLP
Josh Muntner
Chief Financial Officer – Imvax, Inc.
Frank Nestola
Founding Partner – Coefficient Health
Edwin O'Connor
Partner – Goodwin
Tim Opler
CEO – Emerald Bioventures
Maria Luisa Pineda
CEO, Cofounder – Envisagenics, Inc.
Shirly Pinto
Chief Scientific Officer – Kallyope
Andrea Rabney
President and CEO – Argot Partners
Nishta Rao
Citizens Private Bank
Nishta Rao
Citizens Private Bank
Allan Reine
CEO – Prime Medicine Inc
Glenn Rockman
Founder and Managing Partner – Adjuvant Capital
Jason Russell
Managing Director, Global Head of Biotechnology Investment Banking – Morgan Stanley
Eric Schmidt
Analyst – Cantor Fitzgerald
Lacarya Scott
Founding Partner – Tungsten Advisors
Paul J Sekhri
President & CEO – vTv Therapeutics LLC
Romy Seth
Founding Partner – Tungsten Advisors
Allan Shaw
CFO & CBO – CREATE Medicines
Kevin Sheridan
Joint Global Head of Healthcare Investment Banking – Jefferies
Michael Shih
CEO – NeoPhore Ltd.
Brian Skorney
Managing Director – Baird
Kersten Small
Senior Director, Research and Early Development – Juvanescence
Susan Snyder
Managing Partner – Wittkieffer
Bernadette Spina Tiso
Vice President, Deputy General Counsel & Assistant Secretary to the Board of Trustees
New York Blood Center
Bernadette Spina Tiso
Vice President, Deputy General Counsel & Assistant Secretary to the Board of Trustees – New York Blood Center
Lilian Stern
Principal – Stern Investor Relations
Arthur Stril
Chief Business Officer – Cellectis
Graig Suvannavejh
Managing Director – Mizuho Securities USA Inc
Louis Tamayo
Chief Financial Officer – Lexeo Therapeutics
Arthur Tinkelenberg
Chief Operating Officer – Neutargeton Therapeutics
Mark Tomishima
Senior Vice President of Platform Discovery – BlueRock Therapeutics
Nolan Townsend
CEO – Lexio Therapeutics
Gene Trogan
Senior Market Access & Payer Marketing Executive – Celcuity
Richard Truesdell
Partner – David Polk & Wardwell LLP
Kenan Turnacioglu
Chair of Board of Directors – Paige
Ben van der Schaaf
Partner – Arthur D. Little
Sitaram Velaga
Founder, President and CEO – Kenox Pharmaceuticals, Inc
Matthew Vossler
Managing Director – Diversified Search Group
Joe Wolfe
National Life Sciences Business Development Leader – RSM
Alethia Young
CFO – Bicycle Therapeutics
Brett Zbar
Managing Director – General Atlantic